| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lung Neoplasms | 37 | 2025 | 1615 | 4.850 |
Why?
|
| Smoking | 20 | 2023 | 1027 | 2.800 |
Why?
|
| Genome-Wide Association Study | 23 | 2023 | 1631 | 2.170 |
Why?
|
| Genetic Predisposition to Disease | 31 | 2023 | 3066 | 1.940 |
Why?
|
| Scleroderma, Systemic | 12 | 2019 | 117 | 1.920 |
Why?
|
| Polymorphism, Single Nucleotide | 28 | 2023 | 2576 | 1.600 |
Why?
|
| Early Detection of Cancer | 4 | 2025 | 329 | 1.420 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 7 | 2025 | 339 | 1.250 |
Why?
|
| Codon, Nonsense | 3 | 2022 | 131 | 0.960 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2025 | 1976 | 0.700 |
Why?
|
| Genome, Human | 10 | 2020 | 1251 | 0.680 |
Why?
|
| Genetic Variation | 6 | 2020 | 1475 | 0.670 |
Why?
|
| Models, Biological | 3 | 2011 | 1434 | 0.660 |
Why?
|
| Neoplasm Proteins | 4 | 2018 | 670 | 0.660 |
Why?
|
| Tobacco Smoke Pollution | 3 | 2011 | 76 | 0.630 |
Why?
|
| Volatile Organic Compounds | 1 | 2017 | 9 | 0.600 |
Why?
|
| DNA Repair | 3 | 2012 | 584 | 0.580 |
Why?
|
| Breath Tests | 1 | 2017 | 179 | 0.570 |
Why?
|
| Models, Statistical | 7 | 2019 | 445 | 0.560 |
Why?
|
| Case-Control Studies | 19 | 2020 | 3221 | 0.550 |
Why?
|
| Quantitative Trait Loci | 6 | 2022 | 266 | 0.540 |
Why?
|
| Genomic Imprinting | 3 | 2007 | 123 | 0.530 |
Why?
|
| Mutation, Missense | 10 | 2024 | 834 | 0.520 |
Why?
|
| Neoplasms | 8 | 2020 | 2748 | 0.520 |
Why?
|
| Diet | 2 | 2013 | 1099 | 0.500 |
Why?
|
| Humans | 75 | 2025 | 121743 | 0.480 |
Why?
|
| Models, Genetic | 4 | 2008 | 747 | 0.470 |
Why?
|
| Genetic Linkage | 4 | 2007 | 452 | 0.460 |
Why?
|
| Gene Frequency | 7 | 2022 | 707 | 0.460 |
Why?
|
| Carcinogenesis | 1 | 2017 | 332 | 0.460 |
Why?
|
| Risk Factors | 23 | 2023 | 9677 | 0.460 |
Why?
|
| Alleles | 6 | 2020 | 1594 | 0.440 |
Why?
|
| Multivariate Analysis | 4 | 2022 | 1395 | 0.440 |
Why?
|
| Sex Factors | 4 | 2011 | 1226 | 0.430 |
Why?
|
| Introns | 1 | 2014 | 302 | 0.430 |
Why?
|
| Betaine | 1 | 2013 | 22 | 0.430 |
Why?
|
| Choline | 1 | 2013 | 55 | 0.420 |
Why?
|
| Neoplasm Staging | 4 | 2025 | 1225 | 0.420 |
Why?
|
| Selection, Genetic | 3 | 2024 | 150 | 0.410 |
Why?
|
| Middle Aged | 27 | 2020 | 25388 | 0.410 |
Why?
|
| Male | 40 | 2025 | 59138 | 0.400 |
Why?
|
| Computer Simulation | 6 | 2025 | 605 | 0.390 |
Why?
|
| Models, Theoretical | 1 | 2014 | 351 | 0.390 |
Why?
|
| Logistic Models | 8 | 2022 | 1756 | 0.370 |
Why?
|
| Aged | 21 | 2020 | 18464 | 0.370 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2023 | 1891 | 0.370 |
Why?
|
| Odds Ratio | 6 | 2022 | 1226 | 0.370 |
Why?
|
| Evolution, Molecular | 1 | 2014 | 669 | 0.360 |
Why?
|
| Receptors, Nicotinic | 1 | 2011 | 154 | 0.350 |
Why?
|
| Female | 36 | 2025 | 64492 | 0.350 |
Why?
|
| SEER Program | 2 | 2025 | 192 | 0.330 |
Why?
|
| Genetic Loci | 4 | 2016 | 334 | 0.320 |
Why?
|
| Biological Evolution | 4 | 2015 | 220 | 0.310 |
Why?
|
| Research Design | 1 | 2011 | 643 | 0.290 |
Why?
|
| Body Size | 1 | 2007 | 51 | 0.280 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2007 | 73 | 0.280 |
Why?
|
| Prostatic Neoplasms | 5 | 2017 | 1515 | 0.280 |
Why?
|
| Feeding Behavior | 1 | 2011 | 676 | 0.260 |
Why?
|
| Genes, Neoplasm | 2 | 2019 | 79 | 0.260 |
Why?
|
| Data Interpretation, Statistical | 2 | 2005 | 202 | 0.250 |
Why?
|
| Melanoma | 2 | 2023 | 840 | 0.240 |
Why?
|
| Skin Neoplasms | 2 | 2023 | 801 | 0.240 |
Why?
|
| Oncogenes | 2 | 2022 | 172 | 0.230 |
Why?
|
| Gene Expression Profiling | 5 | 2019 | 1674 | 0.230 |
Why?
|
| Family | 1 | 2007 | 569 | 0.230 |
Why?
|
| Genetic Association Studies | 2 | 2022 | 756 | 0.230 |
Why?
|
| Receptors, Interleukin-12 | 2 | 2014 | 9 | 0.220 |
Why?
|
| Neoplasm Metastasis | 2 | 2025 | 651 | 0.220 |
Why?
|
| Interferon Regulatory Factors | 2 | 2014 | 39 | 0.220 |
Why?
|
| Survival Analysis | 2 | 2025 | 1460 | 0.220 |
Why?
|
| Mutation | 4 | 2024 | 5749 | 0.210 |
Why?
|
| RNA Splicing | 3 | 2014 | 224 | 0.210 |
Why?
|
| Software | 1 | 2007 | 671 | 0.200 |
Why?
|
| Nucleotides | 1 | 2022 | 92 | 0.200 |
Why?
|
| Cohort Studies | 8 | 2023 | 4635 | 0.200 |
Why?
|
| Adult | 15 | 2023 | 28623 | 0.200 |
Why?
|
| Lupus Erythematosus, Systemic | 2 | 2014 | 169 | 0.200 |
Why?
|
| Germ-Line Mutation | 2 | 2020 | 312 | 0.190 |
Why?
|
| Prognosis | 5 | 2023 | 4477 | 0.190 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2024 | 649 | 0.190 |
Why?
|
| Exons | 3 | 2014 | 794 | 0.190 |
Why?
|
| Frameshift Mutation | 2 | 2019 | 175 | 0.190 |
Why?
|
| Aged, 80 and over | 9 | 2020 | 6098 | 0.190 |
Why?
|
| Venous Thrombosis | 1 | 2023 | 179 | 0.190 |
Why?
|
| Conserved Sequence | 1 | 2022 | 292 | 0.190 |
Why?
|
| Tumor Burden | 2 | 2012 | 230 | 0.180 |
Why?
|
| Reproducibility of Results | 4 | 2022 | 2792 | 0.180 |
Why?
|
| Venous Thromboembolism | 1 | 2023 | 161 | 0.180 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2020 | 90 | 0.170 |
Why?
|
| Glioblastoma | 1 | 2023 | 327 | 0.170 |
Why?
|
| Obesity | 2 | 2007 | 2082 | 0.160 |
Why?
|
| Genotype | 8 | 2018 | 2533 | 0.160 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2019 | 112 | 0.160 |
Why?
|
| Body Mass Index | 2 | 2005 | 1457 | 0.150 |
Why?
|
| Telomerase | 1 | 2019 | 167 | 0.150 |
Why?
|
| Age Factors | 4 | 2011 | 2769 | 0.150 |
Why?
|
| Octanes | 1 | 2017 | 1 | 0.150 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2017 | 77 | 0.150 |
Why?
|
| DNA-Binding Proteins | 5 | 2022 | 2036 | 0.150 |
Why?
|
| Furans | 1 | 2017 | 27 | 0.150 |
Why?
|
| Computational Biology | 3 | 2015 | 793 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2018 | 159 | 0.150 |
Why?
|
| G1 Phase Cell Cycle Checkpoints | 1 | 2017 | 17 | 0.140 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2020 | 999 | 0.140 |
Why?
|
| Risk | 3 | 2020 | 743 | 0.140 |
Why?
|
| Genomics | 3 | 2014 | 1473 | 0.130 |
Why?
|
| Breast Neoplasms | 2 | 2019 | 2485 | 0.130 |
Why?
|
| Idiopathic Interstitial Pneumonias | 1 | 2016 | 8 | 0.130 |
Why?
|
| CpG Islands | 4 | 2023 | 321 | 0.130 |
Why?
|
| Surveys and Questionnaires | 4 | 2020 | 3619 | 0.130 |
Why?
|
| Rhinitis, Allergic, Seasonal | 2 | 2006 | 24 | 0.130 |
Why?
|
| Age of Onset | 3 | 2012 | 574 | 0.130 |
Why?
|
| Blood | 1 | 2015 | 106 | 0.130 |
Why?
|
| Pedigree | 3 | 2020 | 1575 | 0.130 |
Why?
|
| Linkage Disequilibrium | 2 | 2014 | 305 | 0.120 |
Why?
|
| Adenocarcinoma | 2 | 2020 | 1003 | 0.120 |
Why?
|
| beta Karyopherins | 1 | 2014 | 12 | 0.120 |
Why?
|
| Colonic Neoplasms | 1 | 2017 | 247 | 0.120 |
Why?
|
| Genes, p53 | 2 | 2005 | 215 | 0.120 |
Why?
|
| Likelihood Functions | 2 | 2005 | 106 | 0.110 |
Why?
|
| HLA Antigens | 2 | 2014 | 243 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2014 | 83 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2014 | 83 | 0.110 |
Why?
|
| Environmental Exposure | 1 | 2015 | 215 | 0.110 |
Why?
|
| Lung | 2 | 2023 | 1471 | 0.110 |
Why?
|
| rhoB GTP-Binding Protein | 1 | 2012 | 1 | 0.110 |
Why?
|
| Biomarkers, Tumor | 3 | 2024 | 1424 | 0.100 |
Why?
|
| Europe | 4 | 2019 | 366 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 16 | 2 | 2003 | 150 | 0.100 |
Why?
|
| Food, Organic | 1 | 2011 | 3 | 0.100 |
Why?
|
| Cocarcinogenesis | 1 | 2011 | 23 | 0.100 |
Why?
|
| Autoantibodies | 2 | 2011 | 421 | 0.100 |
Why?
|
| Genetic Markers | 2 | 2011 | 597 | 0.100 |
Why?
|
| Diet, Fat-Restricted | 1 | 2011 | 39 | 0.100 |
Why?
|
| Selection Bias | 1 | 2011 | 19 | 0.100 |
Why?
|
| Membrane Proteins | 1 | 2019 | 1524 | 0.090 |
Why?
|
| Registries | 3 | 2012 | 1351 | 0.090 |
Why?
|
| Eligibility Determination | 1 | 2011 | 38 | 0.090 |
Why?
|
| Vitamin A | 1 | 2011 | 57 | 0.090 |
Why?
|
| Carotenoids | 1 | 2011 | 75 | 0.090 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2013 | 549 | 0.090 |
Why?
|
| Phenotype | 5 | 2012 | 4207 | 0.090 |
Why?
|
| CD3 Complex | 1 | 2010 | 85 | 0.090 |
Why?
|
| Fruit | 1 | 2011 | 215 | 0.090 |
Why?
|
| Interviews as Topic | 1 | 2011 | 368 | 0.090 |
Why?
|
| Forecasting | 1 | 2011 | 353 | 0.080 |
Why?
|
| Genotyping Techniques | 2 | 2020 | 101 | 0.080 |
Why?
|
| Vegetables | 1 | 2011 | 256 | 0.080 |
Why?
|
| Texas | 3 | 2013 | 3521 | 0.080 |
Why?
|
| Databases, Nucleic Acid | 2 | 2008 | 69 | 0.080 |
Why?
|
| Disease | 1 | 2010 | 129 | 0.080 |
Why?
|
| DNA Mutational Analysis | 1 | 2011 | 791 | 0.080 |
Why?
|
| Energy Intake | 1 | 2011 | 450 | 0.080 |
Why?
|
| Nuclear Proteins | 2 | 2013 | 1281 | 0.080 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2011 | 973 | 0.080 |
Why?
|
| Asthma | 2 | 2006 | 742 | 0.080 |
Why?
|
| Motor Activity | 1 | 2011 | 507 | 0.080 |
Why?
|
| Disease Progression | 1 | 2014 | 1970 | 0.070 |
Why?
|
| Confidence Intervals | 1 | 2008 | 275 | 0.070 |
Why?
|
| DNA Breaks | 1 | 2007 | 26 | 0.070 |
Why?
|
| Statistics, Nonparametric | 1 | 2008 | 418 | 0.070 |
Why?
|
| Mutagens | 1 | 2007 | 84 | 0.070 |
Why?
|
| Nerve Tissue Proteins | 1 | 2013 | 1112 | 0.070 |
Why?
|
| Organ Specificity | 2 | 2019 | 426 | 0.070 |
Why?
|
| Proteins | 1 | 2012 | 1046 | 0.070 |
Why?
|
| DNA Methylation | 2 | 2023 | 988 | 0.070 |
Why?
|
| Age Distribution | 1 | 2007 | 399 | 0.070 |
Why?
|
| Dust | 1 | 2006 | 20 | 0.070 |
Why?
|
| Genetics, Population | 2 | 2008 | 183 | 0.070 |
Why?
|
| Epidemiologic Studies | 1 | 2006 | 40 | 0.070 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2014 | 558 | 0.070 |
Why?
|
| Regression Analysis | 1 | 2007 | 755 | 0.060 |
Why?
|
| Promoter Regions, Genetic | 2 | 2023 | 1357 | 0.060 |
Why?
|
| Cell Growth Processes | 1 | 2005 | 63 | 0.060 |
Why?
|
| Radiography, Thoracic | 1 | 2005 | 151 | 0.060 |
Why?
|
| Inflammation | 1 | 2011 | 1393 | 0.060 |
Why?
|
| Regulatory Sequences, Ribonucleic Acid | 1 | 2003 | 16 | 0.060 |
Why?
|
| Lung Diseases | 1 | 2007 | 378 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 20 | 1 | 2003 | 32 | 0.050 |
Why?
|
| Predictive Value of Tests | 2 | 2012 | 2059 | 0.050 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2004 | 296 | 0.050 |
Why?
|
| Body Constitution | 1 | 2002 | 31 | 0.050 |
Why?
|
| Minisatellite Repeats | 1 | 2002 | 43 | 0.050 |
Why?
|
| Sample Size | 1 | 2002 | 78 | 0.050 |
Why?
|
| Monte Carlo Method | 1 | 2003 | 89 | 0.050 |
Why?
|
| Risk Assessment | 2 | 2009 | 3222 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2002 | 111 | 0.050 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2002 | 102 | 0.050 |
Why?
|
| Constriction, Pathologic | 1 | 2023 | 226 | 0.050 |
Why?
|
| Early Diagnosis | 1 | 2003 | 178 | 0.050 |
Why?
|
| Multifactorial Inheritance | 1 | 2002 | 134 | 0.050 |
Why?
|
| Haplotypes | 2 | 2014 | 510 | 0.050 |
Why?
|
| Siblings | 1 | 2002 | 193 | 0.050 |
Why?
|
| Silent Mutation | 1 | 2020 | 3 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2002 | 370 | 0.040 |
Why?
|
| Jews | 1 | 2020 | 31 | 0.040 |
Why?
|
| Chromosome Aberrations | 1 | 2023 | 617 | 0.040 |
Why?
|
| Open Reading Frames | 2 | 2014 | 211 | 0.040 |
Why?
|
| Biomarkers | 2 | 2023 | 2922 | 0.040 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2019 | 31 | 0.040 |
Why?
|
| Ultraviolet Rays | 1 | 2020 | 203 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2023 | 479 | 0.040 |
Why?
|
| Tumor Microenvironment | 1 | 2023 | 552 | 0.040 |
Why?
|
| Epigenesis, Genetic | 1 | 2023 | 666 | 0.040 |
Why?
|
| Child | 3 | 2018 | 24035 | 0.040 |
Why?
|
| Mucins | 1 | 2019 | 72 | 0.040 |
Why?
|
| Algorithms | 3 | 2012 | 1573 | 0.040 |
Why?
|
| Mutation Rate | 1 | 2018 | 65 | 0.040 |
Why?
|
| Gene Ontology | 1 | 2018 | 47 | 0.040 |
Why?
|
| Prospective Studies | 1 | 2009 | 5906 | 0.040 |
Why?
|
| RNA-Binding Proteins | 1 | 2022 | 567 | 0.040 |
Why?
|
| Loss of Function Mutation | 1 | 2019 | 141 | 0.040 |
Why?
|
| Heterozygote | 1 | 2020 | 679 | 0.040 |
Why?
|
| Databases, Genetic | 1 | 2020 | 469 | 0.040 |
Why?
|
| Gene-Environment Interaction | 1 | 2018 | 118 | 0.040 |
Why?
|
| Linear Models | 1 | 2019 | 655 | 0.030 |
Why?
|
| Gene Regulatory Networks | 1 | 2018 | 351 | 0.030 |
Why?
|
| Mass Screening | 2 | 2012 | 776 | 0.030 |
Why?
|
| Young Adult | 2 | 2020 | 8712 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2011 | 11685 | 0.030 |
Why?
|
| Child, Preschool | 2 | 2018 | 13771 | 0.030 |
Why?
|
| Carrier Proteins | 2 | 2014 | 1022 | 0.030 |
Why?
|
| Interleukin-12 Subunit p35 | 1 | 2014 | 6 | 0.030 |
Why?
|
| Autophagy-Related Protein 5 | 1 | 2014 | 12 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2012 | 15601 | 0.030 |
Why?
|
| Microchip Analytical Procedures | 1 | 2014 | 6 | 0.030 |
Why?
|
| Endodeoxyribonucleases | 1 | 2014 | 47 | 0.030 |
Why?
|
| Severity of Illness Index | 2 | 2012 | 2794 | 0.030 |
Why?
|
| Bayes Theorem | 1 | 2014 | 263 | 0.030 |
Why?
|
| Co-Repressor Proteins | 1 | 2013 | 37 | 0.030 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2014 | 116 | 0.030 |
Why?
|
| Adolescent | 2 | 2018 | 18879 | 0.030 |
Why?
|
| Life Style | 1 | 2015 | 391 | 0.030 |
Why?
|
| United States | 3 | 2012 | 10415 | 0.030 |
Why?
|
| Calibration | 1 | 2012 | 82 | 0.030 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2014 | 244 | 0.030 |
Why?
|
| Vital Capacity | 1 | 2012 | 75 | 0.020 |
Why?
|
| Autoimmune Diseases | 1 | 2014 | 248 | 0.020 |
Why?
|
| DNA Topoisomerases, Type I | 1 | 2011 | 20 | 0.020 |
Why?
|
| Airway Remodeling | 1 | 2011 | 20 | 0.020 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 1 | 1 | 2011 | 32 | 0.020 |
Why?
|
| Activin Receptors, Type I | 1 | 2011 | 33 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2012 | 283 | 0.020 |
Why?
|
| Receptors, Cell Surface | 1 | 2013 | 471 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2019 | 2536 | 0.020 |
Why?
|
| Mortality | 1 | 2012 | 221 | 0.020 |
Why?
|
| Cardiovascular Diseases | 1 | 2002 | 1810 | 0.020 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2012 | 147 | 0.020 |
Why?
|
| Genes, Overlapping | 1 | 2008 | 7 | 0.020 |
Why?
|
| 5' Untranslated Regions | 1 | 2008 | 59 | 0.020 |
Why?
|
| 3' Untranslated Regions | 1 | 2008 | 166 | 0.020 |
Why?
|
| 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | 1 | 2007 | 34 | 0.020 |
Why?
|
| Comorbidity | 1 | 2012 | 1473 | 0.020 |
Why?
|
| Survival Rate | 1 | 2012 | 1983 | 0.020 |
Why?
|
| Bleomycin | 1 | 2007 | 151 | 0.020 |
Why?
|
| Family Health | 1 | 2007 | 258 | 0.020 |
Why?
|
| Mice | 1 | 2023 | 17494 | 0.020 |
Why?
|
| Bone Neoplasms | 1 | 2010 | 424 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2018 | 8088 | 0.020 |
Why?
|
| Lod Score | 1 | 2005 | 120 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 13 | 1 | 2005 | 50 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 2005 | 65 | 0.020 |
Why?
|
| Incidence | 1 | 2012 | 2992 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 2005 | 92 | 0.010 |
Why?
|
| MutS Homolog 2 Protein | 1 | 2003 | 37 | 0.010 |
Why?
|
| MutL Protein Homolog 1 | 1 | 2003 | 54 | 0.010 |
Why?
|
| Infant | 1 | 2018 | 12289 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2008 | 1698 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2011 | 4987 | 0.010 |
Why?
|
| Animals | 1 | 2023 | 33670 | 0.010 |
Why?
|
| Adipose Tissue | 1 | 2005 | 446 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2003 | 523 | 0.010 |
Why?
|